Literature DB >> 23996692

Review of neuropathic pain screening and assessment tools.

R Carter W Jones1, Miroslav Misha Backonja.   

Abstract

Chronic pain due to injury to or diseases of the nervous system, known as neuropathic pain (NP), is a common debilitating medication condition for which there are currently several symptomatically effective therapies. Therefore, early identification of NP in the primary and specialty care setting will avoid unnecessary delays in amelioration of symptoms. Given that it is associated with unique symptoms and physical exam signs, several assessment tools have been developed to aid medical practitioners in the identification of patients with NP. The majority of these tools have been developed to differentiate NP from nonNP and to quantify the severity of symptoms that define NP, and some have been used to aid in assessment of response to interventions. This focused review will describe the primary NP assessment tools that are currently available, and discuss their suitability for screening patients and for research applications. Wider use of NP assessment tools will facilitate the development of new therapies, further clarify the epidemiology of this condition, and improve the treatment of NP.

Entities:  

Mesh:

Year:  2013        PMID: 23996692     DOI: 10.1007/s11916-013-0363-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  38 in total

1.  Neuropathic pain in breast cancer survivors: using the ID pain as a screening tool.

Authors:  Cielito Reyes-Gibby; Phuong Khanh Morrow; Michael I Bennett; Mark P Jensen; Sanjay Shete
Journal:  J Pain Symptom Manage       Date:  2010-05       Impact factor: 3.612

2.  Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.

Authors:  B S Galer; M P Jensen
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

3.  Outcome prediction following sympathetic block for complex regional pain syndrome.

Authors:  Craig T Hartrick; Juliann P Kovan; Patti Naismith
Journal:  Pain Pract       Date:  2004-09       Impact factor: 3.183

4.  Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4).

Authors:  Didier Bouhassira; Nadine Attal; Haiel Alchaar; François Boureau; Bruno Brochet; Jean Bruxelle; Gérard Cunin; Jacques Fermanian; Patrick Ginies; Aurélie Grun-Overdyking; Hélène Jafari-Schluep; Michel Lantéri-Minet; Bernard Laurent; Gérard Mick; Alain Serrie; Dominique Valade; Eric Vicaut
Journal:  Pain       Date:  2005-01-26       Impact factor: 6.961

5.  A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4.

Authors:  Isin Unal-Cevik; Saime Sarioglu-Ay; Deniz Evcik
Journal:  J Pain       Date:  2010-04-24       Impact factor: 5.820

6.  Validation and reliability of the Neuropathic Pain Scale (NPS) in multiple sclerosis.

Authors:  David J Rog; Turo J Nurmikko; Tim Friede; Carolyn A Young
Journal:  Clin J Pain       Date:  2007 Jul-Aug       Impact factor: 3.442

7.  The pain quality assessment scale: assessment of pain quality in carpal tunnel syndrome.

Authors:  Mark P Jensen; Arnold R Gammaitoni; David O Olaleye; Napoleon Oleka; Srinivas R Nalamachu; Bradley S Galer
Journal:  J Pain       Date:  2006-11       Impact factor: 5.820

8.  Can the neuropathic pain scale discriminate between non-neuropathic and neuropathic pain?

Authors:  David A Fishbain; John E Lewis; Robert Cutler; Brandly Cole; Hubert L Rosomoff; Rennée S Rosomoff
Journal:  Pain Med       Date:  2008-03       Impact factor: 3.750

9.  Development and validation of the Neuropathic Pain Symptom Inventory.

Authors:  Didier Bouhassira; Nadine Attal; Jacques Fermanian; Haiel Alchaar; Michèle Gautron; Etienne Masquelier; Sylvie Rostaing; Michel Lanteri-Minet; Elisabeth Collin; Jacques Grisart; François Boureau
Journal:  Pain       Date:  2004-04       Impact factor: 6.961

10.  Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves.

Authors:  Gerardo Correa-Illanes; Ricardo Roa; José Luis Piñeros; Wilfredo Calderón
Journal:  Local Reg Anesth       Date:  2012-07-17
View more
  13 in total

Review 1.  Chronic pain assessment from bench to bedside: lessons along the translation continuum.

Authors:  Bryan Jensen
Journal:  Transl Behav Med       Date:  2016-12       Impact factor: 3.046

2.  A PROMIS Measure of Neuropathic Pain Quality.

Authors:  Robert L Askew; Karon F Cook; Francis J Keefe; Cindy J Nowinski; David Cella; Dennis A Revicki; Esi M Morgan DeWitt; Kaleb Michaud; Dace L Trence; Dagmar Amtmann
Journal:  Value Health       Date:  2016-04-06       Impact factor: 5.725

Review 3.  Chemotherapy-induced peripheral neuropathy: where are we now?

Authors:  Lesley A Colvin
Journal:  Pain       Date:  2019-05       Impact factor: 7.926

Review 4.  Pain control following inguinal herniorrhaphy: current perspectives.

Authors:  Martin F Bjurstrom; Andrea L Nicol; Parviz K Amid; David C Chen
Journal:  J Pain Res       Date:  2014-05-29       Impact factor: 3.133

5.  A Genome-wide Association Study Provides Evidence of Sex-specific Involvement of Chr1p35.1 (ZSCAN20-TLR12P) and Chr8p23.1 (HMGB1P46) With Diabetic Neuropathic Pain.

Authors:  Weihua Meng; Harshal A Deshmukh; Louise A Donnelly; Nicola Torrance; Helen M Colhoun; Colin N A Palmer; Blair H Smith
Journal:  EBioMedicine       Date:  2015-08-04       Impact factor: 8.143

6.  The Modified painDETECT Questionnaire for Patients with Hip or Knee Osteoarthritis: Translation into Dutch, Cross-Cultural Adaptation and Reliability Assessment.

Authors:  Wietske Rienstra; Tim Blikman; Frans B Mensink; Jos J A M van Raay; Baukje Dijkstra; Sjoerd K Bulstra; Martin Stevens; Inge van den Akker-Scheek
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

7.  Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.

Authors:  Cholhee Park; Youn-Woo Lee; Duck Mi Yoon; Do Wan Kim; Da Jeong Nam; Do-Hyeong Kim
Journal:  J Korean Med Sci       Date:  2015-08-13       Impact factor: 2.153

8.  A genome-wide association study suggests an association of Chr8p21.3 (GFRA2) with diabetic neuropathic pain.

Authors:  W Meng; H A Deshmukh; N R van Zuydam; Y Liu; L A Donnelly; K Zhou; A D Morris; H M Colhoun; C N A Palmer; B H Smith
Journal:  Eur J Pain       Date:  2015-03       Impact factor: 3.931

9.  Translation and cultural adaptation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale into Arabic for use with patients with diabetes in Libya.

Authors:  Sabri Garoushi; Mark I Johnson; Osama A Tashani
Journal:  Libyan J Med       Date:  2017-12       Impact factor: 1.657

10.  Comparison of the use of opioids only and pregabalin add-on for the treatment of neuropathic pain in cervical myelopathy patients: a pilot trial.

Authors:  Jong-Myung Jung; Chun Kee Chung; Chi Heon Kim; Seung Heon Yang; Yunhee Choi
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.